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The spondylocostal dysostoses (SCDs) are a heterogeneous group of vertebral malsegmentation disorders that arise
during embryonic development by a disruption of somitogenesis. Previously, we had identified two genes that cause
a subset of autosomal recessive forms of this disease: DLL3 (SCD1) and MESP2 (SCD2). These genes are important
components of the Notch signaling pathway, which has multiple roles in development and disease. Here, we have
used a candidate-gene approach to identify a mutation in a third Notch pathway gene, LUNATIC FRINGE (LFNG),
in a family with autosomal recessive SCD. LFNG encodes a glycosyltransferase that modifies the Notch family of
cell-surface receptors, a key step in the regulation of this signaling pathway. A missense mutation was identified
in a highly conserved phenylalanine close to the active site of the enzyme. Functional analysis revealed that the
mutant LFNG was not localized to the correct compartment of the cell, was unable to modulate Notch signaling
in a cell-based assay, and was enzymatically inactive. This represents the first known mutation in the human LFNG
gene and reinforces the hypothesis that proper regulation of the Notch signaling pathway is an absolute requirement
for the correct patterning of the axial skeleton.
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The spondylocostal dysostoses (SCDs) are a group of
disorders characterized by multiple vertebral segmen-
tation defects and rib anomalies (Turnpenny et al. 2003).
SCD is most frequently seen in sporadic cases and with
diverse radiological phenotypes, which are difficult both
to classify and to investigate. Nevertheless, the devel-
opmental mechanisms that produce all these defects in
the embryo are likely to involve abnormal formation of
somites (precursors of vertebra and associated muscu-
lature). In vertebrates, all skeletal muscle of the body,
the axial skeleton, the tendons, and the dorsal dermis
are derived from somites. These are paired blocks of
mesoderm located on either side of the neural tube that
form by a regular wave of segmentation in a rostral-to-
caudal direction throughout the trunk (reviewed by
Pourquie´ [2001]). Somite formation is a reiterative
process—for example, in the mouse, somites segment
from the presomitic mesoderm every 2 h for 8–10.5 d
post coitum (equivalent to human Carnegie stages 9–13
or days 19–29). The Notch signaling pathway is central
to somite formation, and, in the mouse, mutations in
several components of the pathway (Notch1, Dll3, Dll1,
Lfng, Psen1, and CSL) and a downstream target gene
(Hes7) result in abnormal somitogenesis (reviewed by
Weinmaster and Kintner [2003]).
The Notch signaling pathway is an evolutionarily con-
served signal-transduction pathway that has important
roles throughout embryonic development, as well as in
the onset of diseases such as cancer (Harper et al. 2003).
Mechanistically, the pathway is relatively simple, with
ligand-activated signaling mediated by the nuclear trans-
location of the intracellular portion of the receptor to
form part of a transcriptional complex. Notch is a het-
erodimeric one-pass transmembrane receptor. The epi-
dermal growth factor (EGF)–like repeat containing ex-
tracellular fragments mediates interactions with DSL
(Delta, Serrate, and Lag-2) ligands such as Delta-like–1
(Dll1) and Jagged1. The second fragment of Notch spans
the membrane and contains an intracellular domain
(ICD) that mediates Notch signaling. Binding to a ligand
leads to cleavage by a disintegrin and metalloproteinase
and release of the extracellular domain of Notch. A sec-
ond cleavage by g-secretase releases the ICD. The ICD
translocates to the nucleus, forms a complex with the
CSL (CBF1/Su(H)/Lag-1) DNA-binding protein, and
converts it from a repressor to an activator of transcrip-
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Table 1
Primer Sequences
EXON(S)
PRIMER SEQUENCE
(5′r3′)
INTERNAL SEQUENCINGForward Reverse
1:
Pair 1 cgacgggcttcgggtcggtg tcttgacagcgatgaagacg …
Pair 2 agtctgtccgagtacttcag ctggcgtcgcccacagatgg …
2 cacgagtggggaaaccaagg ggcggggcatggagcaaacc …
3 ggagggtccacaggcccaag gggcccgcaggttgacgtag …
4 and 5 tcatcgagtccggcaggaag tgaaacccagagggaagtgg caggcgctgctgcccctcac; cgagaacaaggtggtgagtg
6 tgaggagtgcagcgcctttg tgtttagaacagtgccccac …
7 ccagtttgggaccttattcc catttgcagtcccacaacac …
8 gtgttgtgggactgcaaatg ccccttcacctgtgtgcctc tcttaagccacagcgtccag
tion. Known direct targets of Notch include members of
the hairy/enhancer-of-split (HES) and HES-related fam-
ily of basic helix-loop-helix transcription factors (Iso et
al. 2003) and the glycosyltransferase Lunatic fringe (Mo-
rales et al. 2002).
Elsewhere, we identified two genes that cause a subset
of autosomal recessive forms of SCD: DLL3 (SCD1
[MIM 277300]) (Bulman et al. 2000; Sparrow et al.
2002; Turnpenny et al. 2003; Whittock et al. 2004a)
and MESP2 (SCD2 [MIM 608681]) (Whittock et al.
2004b). Mutations in either of these genes account for
∼20%–25% of all cases of this disorder, with 24 distinct
mutations detected in DLL3 (Bonafe´ et al. 2003; Turn-
penny et al. 2003; Whittock et al. 2004a; authors’
unpublished data) and a single mutation detected in
MESP2 (Whittock et al. 2004b). In this article, we de-
scribe a patient with a skeletal phenotype more severe
than that of previously reported cases of SCD1 and
SCD2. We show that this patient is homozygous for a
missense mutation in the LFNG gene. LFNG is a fucose-
specific b 1,3 N-acetylglucosaminyltransferase that adds
N-acetylglucosamine (GlcNAc) residues to O-fucose on
the EGF-like repeats of Notch receptors (Bruckner et al.
2000; Moloney et al. 2000). LFNG localizes to the
Golgi, where the modification of Notch receptors is be-
lieved to occur (Haines and Irvine 2003). LFNG en-
hances Notch1’s ability to be activated by Dll1 and re-
duces Notch1 signaling when Jagged1 is the activating
ligand. Functional analysis revealed that the mutant
LFNG was not localized to the correct compartment of
the cell, was unable to modify Notch signaling in vitro,
and was enzymatically inactive. Therefore, we conclude
that this missense mutation is likely to be causative of
SCD in this patient.
Material and Methods
Human Subjects
Appropriate informed consent was obtained from the pro-
band and family for this study.
DNA Sequencing
Genomic DNA was sequenced as described elsewhere (Spar-
row et al. 2002), by use of primers listed in table 1.
RFLP Analysis
The F188L mutation produces an MseI restriction site. Con-
trol samples were tested by amplification with primers 5′-GGA-
GGGTCCACAGGCCCAAG-3′ (forward) and 5′-GGGCCCG-
CAGGTTGACGTAG-3′ (reverse) and were digested withMseI
to yield fragments of 413 bp for the wild-type allele and 251
bp and 162 bp for the mutant allele.
In Vitro GlcNAc-Transferase Assays
HEK 293T cells were transfected with expression plasmids
encoding full-length mouse Lfng cDNAs (wild-type and mu-
tants) fused to human IgG1 Fc (at the carboxy terminus). Pro-
tein was affinity purified from either concentrated medium or
whole-cell extract by use of Protein-G-Sepharose beads (Sig-
ma), as described elsewhere (Moloney et al. 2000). GlcNAc-
transferase activity was determined as described elsewhere
(Moloney et al. 2000).
Cell Lines and Coculture Assays
C2C12 and NIH3T3 cells were grown in Dulbecco’s mod-
ified Eagle’s medium containing 10% fetal calf serum. C2C12
cells, which overexpress full-length Notch1, are described else-
where (G. Chapman, L. Liu, C. Dahlqvist, and U. Lendahl,
unpublished data). Control cells, cells overexpressing mouse
Dll1, and cells overexpressing mouse Jagged1 were created by
stably transfecting NIH3T3 cells with pCAGIRESpuro, pCAG-
mDll1-IRESpuro, and pCAG-mJagged1-IRESpuro, respec-
tively. Cultures were grown in 1.5 mg/ml puromycin for 10 d.
Individual mDll1 or mJagged1 stable clones were screened
for expression by western blotting and immunocytochemistry
with rabbit anti-Dll1 or anti-Jagged1 antibodies (Santa Cruz).
Transfections were performed using LipofectAMINE PLUS re-
agent (Invitrogen) in 12-well trays with 14 ng of pCMV-Ren-
illa, 350 ng of p6#TP1-Luc (CSL reporter [Kato et al. 1997]),
and 350 ng of each expression plasmid or pCMV-CAT control
plasmid. Cocultures were performed in triplicate by addition
of NIH3T3 cells stably transfected with vector (con-52# 10
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Figure 1 Radiograph (A) and T2-weighted coronal MRI images (B and C) in the vertebral plane of the proband. A, Severe vertebral
segmentation anomalies throughout the vertebral column. B, Thoracic spine, showing vertebral centers with a fitted angular shape. C, Cervical
and lumbar spine, showing similar segmentation anomalies.
trol cells), mDll1, or mJagged1. Cocultures were harvested in
200 ml of Passive Lysis Buffer (Promega) 24 h after transfection.
Firefly and Renilla luciferase activities were assayed using the
Dual-Luciferase reporter system (Promega) and were measured
on a FLUOstar Optima Luminometer (BMG). Firefly luciferase
counts were normalized against Renilla luciferase counts, to
account for differences in transfection efficiency. Fold activa-
tion of ligand-expressing cells over control NIH3T3 cells was
expressed relative to that of chloramphenicol transferase
(CAT)–transfected cocultures. One-way analysis of variance
was performed on data from four independent experiments.
Significance was determined using Tukey’s post hoc test.
Western Blots and Immunocytochemistry
Western blotting was performed as described elsewhere (G.
Chapman, L. Liu, C. Dahlqvist, and U. Lendahl, unpublished
data). Confocal immunofluorescence of hemagglutinin (HA)–
tagged Lfng and mutants was done as described elsewhere
(Dahlqvist et al. 2003), by use of a TCS SP confocalmicroscope
(Leica Microsystems). Antibodies used were obtained from
Santa Cruz (Lfng), Clontech (rabbit anti-HA), Covance (mouse
anti-HA), and BD transduction labs (GM130).
Results
The proband was of Lebanese background and pre-
sented with extensive congenital vertebral anomalies;
long, slender fingers; and camptodactyly of the left index
finger. X-ray (fig. 1A) and magnetic resonance imaging
(MRI) scans (fig. 1B) showed multiple vertebral ossifi-
cation centers in the thoracic spine, which showed fitted
angular shapes similar to those seen in the patient with
SCD2 who was described elsewhere (Whittock et al.
2004b). Severe foreshortening of the spine is emphasized
by the comparison of the patient’s arm span (186.5 cm)
with adult height (155 cm; lower segment 92.5 cm).
The patient had nonprogressive scoliosis of the cervical
and thoracic spine. However, in contrast to SCD2, ver-
tebral anomalies were also present in the cervical and
lumbar spine (fig. 1A and 1C). Vertebral anomalies along
the whole length of the spine are a feature of SCD1;
however, in SCD1, the vertebrae have a more rounded
shape (“pebble beach” sign [Turnpenny et al. 2003])
than in this case. Although vertebral shape is known to
change with increasing age—with vertebrae becoming
less rounded andmore angular—the proband clearly had
a spine more severely disorganized (throughout all the
vertebral bodies) than that in the majority of SCD1 cases
seen so far and much more severe than the singly re-
ported sibling cases with an SCD2 mutation. Analysis
of the entire coding region and splice sites of DLL3
revealed no deviations from the published sequence.
Likewise, no mutations were found in theMESP2 coding
region for this patient.
We therefore sought to identify other candidate genes
for sequencing in this patient. Using the Dll3 null mouse
as a model for SCD, we have shown that SCD is caused
by a defect in the formation of embryonic structures
called “somites,” which are the precursors of the axial
skeleton, tendons, muscle, and the dorsal dermis (Dun-
woodie et al. 2002). The Notch signaling pathway is
central to the regulation of this process (reviewed by
Weinmaster and Kintner [2003]). Indeed, both of the
genes thus far implicated in causing SCD encode com-
ponents of this signaling pathway: DLL3 is a ligand for
the Notch family of signaling receptors, and MESP2 is
a downstream target of Notch signaling. Deletion of
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Figure 2 Detection of the c.564CrA mutation. A, Electropherograms documenting the affection status of the proband and parents.
B, Confirmation of the presence of the c.564CrA mutation by MseI RFLP in genomic DNA isolated from an unrelated control individual, the
proband, and the proband’s mother and father.
Figure 3 Structural model of LFNG, showing the proximity of
the mutated phenylalanine residue (orange) to the Mn2 binding site
(Mn2 in purple). Directly interacting residues F196 and H198 are
shown in cyan, and the nearby Mn2-ligating residues D202 and D203
are in red. The position of the UDP-sugar donor group (green) and
an acceptor sugar (yellow) are shown for reference. a-helices and b-
sheets are colored in a gradient from dark blue (amino terminus) to
red (carboxy terminus).
other components of the Notch signaling pathway in the
mouse also causes somite dysmorphology, and these mu-
tants represent the majority of defects in somitogenesis
reported thus far (see Sparrow et al. 2002). We therefore
examined the phenotypes of such mouse lines in detail,
in an effort to identify further candidate genes for se-
quencing in our patient. The phenotypes ofDll3 (pudgy)
and Lfng null mice were virtually identical (Zhang et al.
2002), indicating that murine somitogenesis is similarly
dependent on each gene. LFNG is a fucose-specific b 1,3
N-acetylglucosaminyltransferase (Bruckner et al. 2000;
Moloney et al. 2000) that functions in the Golgi to post-
translationally modify the Notch receptors, altering their
signaling properties (Haines and Irvine 2003). Further-
more, our previous analysis revealed that Lfng gene
expression is severely disregulated in Dll3 null mice,
suggesting that Lfng expression is dependent on Dll3
function (Dunwoodie et al. 2002; Kusumi et al. 2004).
We sequenced the entire coding region and splice sites
of the LFNG gene in the proband (fig. 2A), using prim-
ers listed in table 1. A homozygous missense mutation
(c.564CrA) in exon 3 was detected that results in sub-
stitution of leucine for phenylalanine (F188L). Sequenc-
ing of DNA from the proband’s parents, who had nor-
mal spinal and hand anatomy, confirmed that they were
both heterozygous for the mutant allele. A number of
approaches were taken to demonstrate that this base
change was not a common polymorphism unassociated
with the SCD phenotype. The mutation created a novel
MseI restriction enzyme site, and the resultant RFLP
was used to confirm the sequencing results in the pedi-
gree (fig. 2B). The MseI polymorphism was not found
in 125 control subjects (250 chromosomes), giving∼80%
power to distinguish a normal sequence variant from a
mutation (Collins and Schwartz 2002). In addition, the
underlying base substitution was not present in the
National Center for Biotechnology Information SNP da-
tabase (dbSNP Web site).
Structural Consequences of the F188L LFNG Mutation
The mutated phenylalanine is absolutely conserved in
all known fringe proteins, from Drosophila melanogas-
ter to humans (Correia et al. 2003). Examination of the
mutation within an LFNG model based on solved gly-
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cosyltransferase structures suggests that the conserved
phenylalanine residue (F188) is not directly involved in
uridine diphosphate (UDP)–GlcNAc (donor) or protein
binding (fig. 3). Rather, it is likely to reside in a helix
that packs against the strand containing the Mn2-
ligating residues D200 and the nearby D202. F188 is
predicted to form an aromatic cluster with residues F196
and H198, and thus the F188L mutation may either
cause steric perturbation of the Mn2 binding site by
altered packing of the smaller mutant (leucine) residue
or cause electronic disruption of the enzymatic reaction
by removal of required p-p interactions associated with
the aromatic ring. Further details of structural modeling
techniques are given in appendix A (online only).
Functional Analysis of the F188L LFNG Mutation
To provide evidence that this was, indeed, an SCD-
causative mutation, we undertook a range of assays to
assess the function of the LFNG mutant. Since no full-
length human cDNA was available, we created two
F187L mutations in mouse Lfng that correspond to
F188L in human LFNG: a c.564CrAmutation encoding
the rare leucine codon (TTA) observed in the proband
and the c.562TrC  c.567CrG mutation encoding the
most common human leucine codon (CTG). In addition,
a previously characterized, enzymatically inactive form
of Lfng (D202A) was created that disrupts the conserved
DDD Mn2 binding active site (Chen et al. 2001). We
initially examined whether the mutant proteinwas stable
and efficiently expressed, since, in addition to the po-
tential destabilization of the protein by amino acid sub-
stitution, the presence of low-frequency codons in tran-
scripts has been shown to cause stalling of translation
machinery, transcript degradation, and lowered levels of
protein expression (Lemm and Ross 2002). HA-tagged
versions of Lfng were transiently transfected intoC2C12
cells, and protein levels were determined by western blot
(fig. 4A). Both F187L mutant Lfng proteins were ex-
pressed at higher levels than the wild-type or D202A
Lfng forms, indicating that both translation efficiency
and protein stability were not adversely affected by the
F187L amino acid change or the presence of a low-
frequency codon in the transcript. In all subsequent as-
says, the TTA and CTG mutants behaved identically
(figs. 4A, 5A, and 5B and data not shown).
Lfng protein is normally present in the Golgi appa-
ratus. To determine whether the F187L mutation af-
fected the targeting of Lfng, intracellular protein local-
ization was examined using immunofluorescence (fig.
4B–4D). Wild-type and D202A mutant Lfng were lo-
calized predominantly to the Golgi, as assessed by co-
staining with the Golgi-specific marker GM130 (fig. 4B
and 4C). By contrast, the F187L mutant Lfng did not
colocalize with GM130 (fig. 4D). Therefore, we con-
clude that the F187L mutant form of Lfng is expressed
but is mislocalized within the cell.
To assess the effect of the F187L mutation on Lfng
function, we used a cell coculture assay described else-
where (Hicks et al. 2000; G. Chapman, L. Liu, C.
Dahlqvist, and U. Lendahl, unpublished data). In this
system, C2C12 myoblasts expressing the mouse Notch1
receptor (i.e., responding cells) were cocultured with
NIH3T3 cells expressing either mouse Dll1 or Jagged1
ligands. Prior to coculture, responding cells were tran-
siently transfected with a luciferase reporter gene driven
by multiple copies of the Notch signaling–responsive
CSL binding site (Kato et al. 1997). After coculture for
24 h, luciferase levels were determined, to measure the
extent of Notch signaling in the responding cells. Ex-
pression of wild-type Lfng in responding cells acted to
potentiate Dll1 signaling (fig. 6A) and to inhibit Jagged1
signaling (fig. 6B), as reported elsewhere (Hicks et al.
2000; Shimizu et al. 2001). However, when either the
F187L or the D202A mutant forms of Lfng were used
in these assays, they had little or no effect on the levels
of Notch signaling induced by Dll1 or Jagged1 in the
responding cells. These data indicate that the F187Lmu-
tation renders Lfng functionally inactive in these Notch
signaling assays.
The incorrect subcellular localization of the F187L
Lfng could be responsible for the failure of this mutant
to function in Notch signaling, and thus it is possible
that this form of Lfng is still capable of modifying the
Notch receptors. Therefore, to assess the enzymatic ac-
tivity of the wild-type and mutant Lfng proteins, we
performed a GlcNAc-transferase assay in vitro. Car-
boxy-terminal Fc-tagged versions of wild-type or mu-
tated forms of Lfng were expressed in 293T cells and
were affinity purified from medium, as described else-
where (Moloney et al. 2000), and protein levels were
analyzed by immunoblot with an Lfng-specific antibody
(fig. 5A). Although Lfng is normally considered to be
localized to and function in the Golgi apparatus in vivo
(Bruckner et al. 2000; Munro and Freeman 2000), when
it is overexpressed in cultured cells, significant amounts
of protein are secreted into the medium. This is a com-
mon feature when Golgi glycosyltransferases are over-
expressed, but it is not known whether the secreted form
serves any biological function, although evidence from
the Drosophila homologue (Fringe) suggests that the
major function of the protein occurs within the Golgi
(Bruckner et al. 2000; Munro and Freeman 2000). In
keeping with our subcellular localization results, wild-
type and D202A mutant forms of Lfng were efficiently
secreted from the cell, but only small amounts of F187L
Lfng were present in conditioned medium (2%–3% of
normal protein levels) (fig. 5A). This is likely to be the
result of a defect in protein secretion, since the F187L
mutation does not affect protein translation and stability
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Figure 4 A, Relative expression of transfected wild-type and
mutant Lfng proteins. Shown is western blot detection of Lfng in
lysates from C2C12 cells transfected with HA-tagged wild-type, TTA
F187L, CTG F187L, and D202A Lfng. A total of 50 mg of each lysate
was run on a 4%–12% PAGE gel and was blotted. Lfng proteins were
detected using a mouse anti-HA antibody. Western blot detection of
b-actin was performed to control for loading. B–D, Immunofluores-
cence analysis of wild-type and mutant Lfng proteins in cultured cells.
F187L Lfng does not localize to the Golgi. C2C12 myoblasts were
transiently transfected with constructs encoding HA-tagged wild-type
Lfng (B), D202A mutant Lfng (C), and F187L Lfng (D). In each case,
the top panel shows a confocal image of immunofluorescence with a
rabbit anti-HA antibody, and the middle panel with the Golgi-specific
antibody (GM130); the bottom panel shows a merged image. The scale
bar represents 25 mm.
within the cell (fig. 4A). Therefore, the protein purifi-
cation was repeated using a whole-cell protein extract.
As expected, all four proteins were detectable (fig. 5A).
Affinity-purified protein derived from whole-cell extract
was then used in an in vitro GlcNAc-transferase assay
with the use of p-nitrophenyl-a-L-fucose (which struc-
turally mimicsO-linked fucose) as an acceptor andUDP-
[3H]GlcNAc as a donor substrate (Moloney et al. 2000).
The difference in size between protein purified from con-
ditioned medium and protein purified from whole-cell
extract may be indicative of the absence of pro-protein
processing. However, there was no discernible difference
in the relative in vitro enzymatic activity of wild-type
protein purified from either source (data not shown). As
shown in figure 5B, the F187L (TTA and CTG) and
D202A mutants showed no enzymatic activity above
background, whereas wild-type Lfng showed activity
similar to that described elsewhere (Chen et al. 2001).
This demonstrates that F187 is necessary for GlcNAc-
transferase activity and that substitution of leucine at
this site renders the enzyme inactive.
Discussion
Our data strongly support the hypothesis that the F188L
missense mutation of LFNG is causative of SCD in the
proband, because it is not localized to the correct com-
partment of the cell, is unable to modulate Notch sig-
naling in the same manner as the wild-type protein, and
is enzymatically inactive. We propose that this form of
SCD be referred to as “SCD3” because mutation in
LFNG demonstrates that this case is genetically distinct
from SCD1 and SCD2. The proband has a more severely
disorganized spine, compared with the majority of SCD1
cases seen so far, and certainly compared with the SCD2
cases; however, clear differentiation in phenotype be-
tween cases of SCD caused by mutation in DLL3,
MESP2, and LFNG cannot be confirmed until more pa-
tients with mutations in LFNG (and MESP2) are un-
covered. It is unclear how frequent such mutations are
within the group of patients with costovertebral defects,
since we have, to date, only sequenced the LFNG gene
for 28 patients with SCD who lack mutations in both
DLL3 and MESP2. Discovery that mutation in a third
gene causes a discernible SCD phenotype emphasizes the
importance of detailed examination of the vertebral
anomalies of patients with SCD to assist diagnosis of
the underlying genetic defect in this group of vertebral
segmentation disorders.
In contrast to the apparent situation in humans, close
analysis of the vertebral phenotypes in mice lackingDll3
(Dunwoodie et al. 2002), Mesp2 (Saga et al. 1997), or
Lfng (Zhang and Gridley 1998) shows no obvious dif-
ferences in either the appearance of vertebrae or the
extent of malformation along the rostral-caudal axis.
Therefore, it is possible that differences are observed in
the human phenotypes because the expression of these
genes in humans is different from the expression in mice.
In the mouse, detailed expression profiles during somito-
genesis have been established for Dll3 (Dunwoodie et
al. 1997), Mesp2 (Saga et al. 1997), and Lfng (Forsberg
et al. 1998; Aulehla and Johnson 1999). In contrast,
nothing is known about the expression of these genes
during somite formation in humans. It is also possible
that the differences between mouse and human pheno-
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Figure 5 Results showing that F187 Lfng is enzymatically in-
active. A, Western blot using an Lfng-specific antibody on Lfng-Fc
fusion protein that was affinity purified from conditioned medium
(“secreted”) or whole-cell extract (“intracellular”) derived from tran-
siently transfected HEK 293T cells. B, GlcNAc-transferase assays per-
formed on Lfng that was affinity purified from whole-cell extract by
use of pNp-fucose (4 mM) as an acceptor and UDP-[3H]GlcNAc as
a donor. Assays were performed in duplicate, and error bars represent
SDs of the mean.
types are the result of the nature of the causative mu-
tations, rather than being intrinsic to the genes them-
selves. Here, we have shown that the LFNG F188L
mutation is equivalent to a null allele. Likewise, the ma-
jority of DLL3 mutations are probably also null alleles
(Turnpenny et al. 2003). In contrast, the only known
MESP2 mutant allele produces a truncated protein that
retains its DNA-binding domain and may possess some
of its normal function. This may explain the lesser extent
of the phenotype along the vertebral column in the pa-
tients with the MESP2 mutation than that in the patients
with DLL3 and LFNG mutations.
In addition to vertebral anomalies, the proband has
long, slender fingers and camptodactyly of the left index
finger. We feel that this is unlikely to be a consequence
of the mutation in LFNG, since mouse embryos lacking
Lfng expression do not show limb defects (Zhang et al.
2002) and, within the developing vertebrate limb, Lfng
expression is limited to hemangioblasts, the precursors
of blood vessels. However, the exact expression pattern
of LFNG in the human embryo remains to be investi-
gated, and it is formally possible that human limb de-
velopment differs from that in the mouse. It should also
be noted that another member of the fringe family, Rad-
ical fringe (Rfng), is expressed in the apical ectodermal
ridge in both mouse and chick. This is a key organizing
center in the developing vertebrate limb that has several
distinct roles in embryonic limb formation (Capdevila
and Izpisua Belmonte 2001). The role of Rfng within
the developing limb is controversial because studies in
the chick and mouse show differences. In the chick, ec-
topic overexpression of Rfng in the developing limb
causes a disruption of normal limb formation (Laufer et
al. 1997; Rodriguez-Esteban et al. 1997). However, in
mouse embryos lacking Rfng, no overt phenotype is seen
in the limb or elsewhere (Moran et al. 1999; Zhang and
Gridley 1999; Zhang et al. 2002). Furthermore, mouse
embryos lacking both Lfng and Rfng show an identical
phenotype to Lfng null embryos, with no overt limb
deformity (Zhang et al. 2002). These discrepancies may
be caused by differences between chick and mouse limb
formation or by differences in experimental approach
(i.e., overexpression vs. gene deletion). Additional pa-
tients with mutation in LFNG will show whether there
is a correlation between the mutation and the pres-
ence of camptodactyly; however, an anomaly of a sin-
gle finger could possibly be a secondary consequence
of the cervical segmentation phenotype through nerve
entrapment.
Lfng is expressed in a number of other locations in
the developing mouse embryo, including the segmenting
hindbrain, neural crest migrating into the branchial
arches, olfactory placode, inner ear, lung, kidney, thy-
mus, ovary, and teeth (Cohen et al. 1997; Johnston et
al. 1997; Zhang et al. 2000; Koch et al. 2001; Mustonen
et al. 2002; Leimeister et al. 2003; Hahn et al. 2005;
van Tuyl et al. 2005). Because of a reduced viability of
the Lfng null mouse line, phenotypic assessment of these
organs in null mice has been limited to the inner ear
(Zhang et al. 2000) and the ovary (Hahn et al. 2005).
In the latter case, female null mice have been shown to
be infertile because of defects in the meiotic maturation
of oocytes. The availability of a null LFNG allele in
humans provides a valuable opportunity to explore the
consequence of a loss of LFNG beyond the axial skel-
eton. In particular, LFNG is expressed in restricted
regions of the developing brain and nervous system, and
thus clinical neurological investigation of the proband
may be useful to further elucidate the importance of
modulation of Notch signaling in the development of
the brain.
It is not clear how the F188L mutation leads to a loss
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Figure 6 Results showing that F187L Lfng does not modulate
ligand-induced Notch signaling. A, Wild-type Lfng significantly po-
tentiates activation of Notch1 by coculture with Dll1-expressing cells,
whereas F187L and D202A mutants do not alter levels of Notch1
activation. Three asterisks (***) denote for wild-type versusP ! .001
F187L Lfng. B, Wild-type Lfng significantly inhibits activation of
Notch1 by coculture with Jagged1-expressing cells, whereas F187L
and D202A mutants do not alter levels of Notch1 activation. Three
asterisks (***) denote for wild-type versus F187L Lfng.P ! .001
Notch1 cells were cotransfected with plasmids encoding wild-type
Lfng, mutant Lfng, or CAT (as a negative control) and a CSL reporter.
Transfected cells were cocultured with either control NIH3T3, Dll1,
or Jagged1 cells and were assayed for luciferase activity. Fold activation
of ligand-expressing cells over control NIH3T3 cells is expressed rel-
ative to that of CAT-transfected cocultures. Notch signaling was ac-
tivated 4–10-fold in these experiments. Error bars represent SDs of
four independent experiments.
of subcellular localization of Lfng in the Golgi, especially
since the D202A mutant (which also lacks enzymatic
activity) is localized correctly. It is possible that this mu-
tation has uncovered a new nonenzymatic functional
domain in the Lfng protein that is required to bind an-
other protein or chaperone to achieve proper subcellular
localization. Such a dual role for a glycosyltransferase
has been recently described for the Drosophila protein
O-fucosyltransferase (Okajima et al. 2005). This enzyme
adds an O-fucose residue to the Notch receptor to create
the substrate for the fringe family of glycosyltransferases.
However, this protein is likely to possess a nonenzymatic
ability to facilitate folding of the Notch receptor and
subsequent trafficking out of the endoplasmic reticulum
to the Golgi.
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